SCHEMBL5336150

SCHEMBL5336150

SCCCCCCCCCCCc1ccc(-c2ccc(-c3cccs3)s2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.57
LTA4H P09960 1/20 0.54
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 2/20 0.41
GLA P06280 1/20 0.41
MAPT P10636 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL799787 0.98 LTA4H (0.56) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL799496 0.94 DPP4 (0.60) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL799475 0.92 LTA4H (0.59) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL799557 0.87 DPP4 (0.64) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL799958 0.85 LTA4H (0.62) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL2028518 0.84 DPP4 (0.57) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL14284941 0.84 DPP4 (0.57) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL2769963 0.84 DPP4 (0.57) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL28000383 0.83 LTA4H (0.65) DPP4LTA4HALDH1A1LMNAL3MBTL1
SCHEMBL28000384 0.83 DPP4 (0.58) DPP4LTA4HALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531155-B1 Asymmetrical linear organic oligomers STARCK H C GMBH CO KG (DE) 2007-08-01 EP disclosed
US-7196206-B2 A series of aromatic rings carrying a linear alkylene chain substituted with a polar group, e.g., 5-ethyl-5'''-(10-undecenyl)-2,2':5',2'':5'',2'''-quaterthiophene; thin films having the function of a dielectric layer and of a semiconductive layer; a self-assembled molecule (SAMS); low surface voltage H.C. STARCK GMBH & CO. KG (DE) 2007-03-27 US disclosed
US-20050139822-A1 Asymmetrical linear organic oligomers HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2005-06-30 US disclosed
EP-1531155-A1 Asymmetrical linear organic oligomers H.C. Starck GmbH (DE) 2005-05-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050139822-A1 Asymmetrical linear organic oligomers ATXN2, OR10J3, ATXN10 DPP4 4882/4885LTA4H 1761/4885ALDH1A1 3304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.